Sign in Register

Drug class

Selective Norepinephrine RU Inhibitors (Sel-NARI)

The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature. Read more about Selective Norepinephrine RU Inhibitors (Sel-NARI)

19 drugs in this class 19 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Attention-Deficit Hyperactivity DisorderTop indication · 352 prescription drugs

Showing 1–9 of 19 drugs

Sort

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

RISING PHARM

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

PRASCO LABS

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

GLENMARK PHARMA

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

TEVA USA

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

APOTEX CORP

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

NORTHSTAR RX LL

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

DR.REDDY'S LAB

QELBREE (viloxazine HCl)

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

SUPERNUS PHARMA

ATOMOXETINE HCL

ANTIDEPRESSANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER

Major Pharamceuticals

Filter & compare in the drug finder → Opens the drug finder with Selective Norepinephrine RU Inhibitors (Sel-NARI) preselected. Add indication or manufacturer filters there.

About Selective Norepinephrine RU Inhibitors (Sel-NARI).

The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature.

Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central nervous system.

They are primarily utilized in the management of attention-deficit/hyperactivity disorder (ADHD), with representative agents such as atomoxetine and viloxazine, as well as in major depressive disorder across certain international regulatory jurisdictions.

redsailtechnologies.com
The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature
primetherapeutics.com
The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature
nih.gov
The phrase "Selective Norepinephrine RU Inhibitors (Sel-NARI)" is an administrative or formulary classification abbreviation—where "RU" denotes "reuptake"—rather than a standard standalone clinical nomenclature Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central...
wikipedia.org
Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central nervous system They are primarily utilized in the management of attention-deficit/hyperactivity disorder (ADHD), with representative agents such as atomoxetine and viloxazine, as well as in major depressive dis...
lens.com
Clinically recognized as selective norepinephrine (or noradrenaline) reuptake inhibitors (sNRIs or NARIs), these agents selectively inhibit the presynaptic norepinephrine transporter (NET) to prevent the reuptake of norepinephrine and prolong noradrenergic neurotransmission in the central nervous system They are primarily utilized in the management of attention-deficit/hyperactivity disorder (ADHD), with representative agents such as atomoxetine and viloxazine, as well as in major depressive dis...